Related references
Note: Only part of the references are listed.Cause of death in patients with poststroke epilepsy: Results from a nationwide cohort study
Julia Hansen et al.
PLOS ONE (2017)
Valproate induced hepatic steatosis by enhanced fatty acid uptake and triglyceride synthesis
Xupeng Bai et al.
TOXICOLOGY AND APPLIED PHARMACOLOGY (2017)
Antiepileptic drug use for treatment of epilepsy and dyslipidemia: Systematic review
Manav V. Vyas et al.
EPILEPSY RESEARCH (2015)
Evidence-based guideline: Management of an unprovoked first seizure in adults: Report of the Guideline Development Subcommittee of the American Academy of Neurology and the American Epilepsy SocietyCommentary Author Response
Allan Krumholz et al.
NEUROLOGY (2015)
Valproic acid and nonalcoholic fatty liver disease: A possible association?
Edoardo Farinelli et al.
WORLD JOURNAL OF HEPATOLOGY (2015)
A high risk of hyperlipidemia in epilepsy patients: a nationwide population-based cohort study
Tomor Harnod et al.
ANNALS OF EPIDEMIOLOGY (2014)
The Medicinal Chemistry of Liver X Receptor (LXR) Modulators
Colin M. Tice et al.
JOURNAL OF MEDICINAL CHEMISTRY (2014)
Effects of long-term antiepileptic drug monotherapy on vascular risk factors and atherosclerosis
Yao-Chung Chuang et al.
EPILEPSIA (2012)
Involvement of fatty acid metabolism in the hepatotoxicity induced by divalproex sodium
W. Wang et al.
HUMAN & EXPERIMENTAL TOXICOLOGY (2012)
Liver-Specific Expression of Transcriptionally Active SREBP-1c Is Associated with Fatty Liver and Increased Visceral Fat Mass
Birgit Knebel et al.
PLOS ONE (2012)
Risk of mortality among patients with epilepsy in southern Taiwan
Ya-Hui Chang et al.
SEIZURE-EUROPEAN JOURNAL OF EPILEPSY (2012)
Human SREBP1c Expression in Liver Is Directly Regulated by Peroxisome Proliferator-activated Receptor α (PPARα)
Ana Fernandez-Alvarez et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2011)
Validation of the National Health Insurance Research Database with ischemic stroke cases in Taiwan
Ching-Lan Cheng et al.
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY (2011)
Molecular and Therapeutic Potential and Toxicity of Valproic Acid
Sebastien Chateauvieux et al.
JOURNAL OF BIOMEDICINE AND BIOTECHNOLOGY (2010)
Participation of lipid transport and fatty acid metabolism in valproate sodium-induced hepatotoxicity in HepG2 cells
Qiaoli Ji et al.
TOXICOLOGY IN VITRO (2010)
Increased risk and worse prognosis of myocardial infarction in patients with prior hospitalization for epilepsy-The Stockholm Heart Epidemiology Program
Imre Janszky et al.
BRAIN (2009)
Antiepileptic drug utilization in Taiwan: Analysis of prescription using National Health Insurance database
Liang-Po Hsieh et al.
EPILEPSY RESEARCH (2009)
Non-alcoholic fatty liver disease (NAFLD), insulin resistance and lipid profile in antiepileptic drug treatment
G. Luef et al.
EPILEPSY RESEARCH (2009)
Adverse events with use of antiepileptic drugs: a prescription and event symmetry analysis
Ioannis Tsiropoulos et al.
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY (2009)
Liver X receptor in cooperation with SREBP-1c is a major lipid synthesis regulator in nonalcoholic fatty liver disease
Nobito Higuchi et al.
HEPATOLOGY RESEARCH (2008)
Epilepsy in the elderly
Gina Mapes Jetter et al.
SEMINARS IN NEUROLOGY (2008)
Subchronic effects of valproic acid on gene expression profiles for lipid metabolism in mouse liver
Min-Ho Lee et al.
TOXICOLOGY AND APPLIED PHARMACOLOGY (2008)
Assessing the effects of LXR agonists on cellular cholesterol handling: a stable isotope tracer study
Karpagam Aravindhan et al.
JOURNAL OF LIPID RESEARCH (2006)
Serum thyroid hormone balance and lipid profile in patients with epilepsy
SA Hamed et al.
EPILEPSY RESEARCH (2005)
Skeletal muscle lipid accumulation in type 2 diabetes may involve the liver X receptor pathway
ET Kase et al.
DIABETES (2005)
Detailed analysis of grid-based molecular docking: A case study of CDOCKER - A CHARMm-based MD docking algorithm
GS Wu et al.
JOURNAL OF COMPUTATIONAL CHEMISTRY (2003)
Stimulation of lipogenesis by pharmacological activation of the liver X receptor leads to production of large, triglyceride-rich very low density lipoprotein particles
A Grefhorst et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
Drug-induced lipid changes - A review of the unintended effects of some commonly used drugs on serum lipid levels
AK Mantel-Teeuwisse et al.
DRUG SAFETY (2001)
Role of LXRs in control of lipogenesis
JR Schultz et al.
GENES & DEVELOPMENT (2000)
Regulation of mouse sterol regulatory element-binding protein-1c gene (SREBP-1c) by oxysterol receptors, LXRα and LXRβ
JJ Repa et al.
GENES & DEVELOPMENT (2000)
Human white/murine ABC8 mRNA levels are highly induced in lipid-loaded macrophages - A transcriptional role for specific oxysterols
A Venkateswaran et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2000)
Share Paper
